Citadel Advisors LLC Sells 3,898 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Citadel Advisors LLC decreased its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 36.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,817 shares of the medical instruments supplier's stock after selling 3,898 shares during the period. Citadel Advisors LLC owned approximately 0.13% of Mesa Laboratories worth $899,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Raymond James Financial Inc. purchased a new stake in Mesa Laboratories in the 4th quarter valued at approximately $32,677,000. Ameriprise Financial Inc. lifted its stake in shares of Mesa Laboratories by 191.8% during the 4th quarter. Ameriprise Financial Inc. now owns 151,862 shares of the medical instruments supplier's stock worth $20,026,000 after purchasing an additional 99,819 shares during the period. Conestoga Capital Advisors LLC raised its position in shares of Mesa Laboratories by 8.3% in the 4th quarter. Conestoga Capital Advisors LLC now owns 573,037 shares of the medical instruments supplier's stock worth $75,566,000 after buying an additional 43,927 shares during the period. Jane Street Group LLC raised its position in shares of Mesa Laboratories by 1,390.4% in the 4th quarter. Jane Street Group LLC now owns 34,399 shares of the medical instruments supplier's stock worth $4,536,000 after buying an additional 32,091 shares during the period. Finally, Diamond Hill Capital Management Inc. purchased a new position in shares of Mesa Laboratories in the 4th quarter worth $3,512,000. Institutional investors and hedge funds own 90.60% of the company's stock.

Mesa Laboratories Price Performance

Mesa Laboratories stock traded down $2.66 during mid-day trading on Monday, hitting $97.96. The company's stock had a trading volume of 60,987 shares, compared to its average volume of 39,996. The company has a quick ratio of 0.53, a current ratio of 0.71 and a debt-to-equity ratio of 0.61. The stock has a market capitalization of $534.37 million, a P/E ratio of -2.12 and a beta of 0.97. Mesa Laboratories, Inc. has a twelve month low of $83.68 and a twelve month high of $155.12. The stock's fifty day moving average price is $114.78 and its two-hundred day moving average price is $126.29.

Mesa Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Friday, May 30th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date is Friday, May 30th. Mesa Laboratories's dividend payout ratio is currently -172.97%.

Insider Activity at Mesa Laboratories

In other news, CEO Gary M. Owens sold 21,000 shares of Mesa Laboratories stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $123.91, for a total transaction of $2,602,110.00. Following the transaction, the chief executive officer now directly owns 43,337 shares of the company's stock, valued at $5,369,887.67. This trade represents a 32.64% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 4.40% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several brokerages recently issued reports on MLAB. Wells Fargo & Company lowered their price target on Mesa Laboratories from $120.00 to $100.00 and set an "underweight" rating for the company in a report on Friday. Wall Street Zen downgraded Mesa Laboratories from a "strong-buy" rating to a "buy" rating in a research note on Friday.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.